Evidence map›Paper›PMID 29480936›Full record

ArticleThe European journal of neuroscience2018

TrkB-mediated activation of the phosphatidylinositol-3-kinase/Akt cascade reduces the damage inflicted by oxygen-glucose deprivation in area CA3 of the rat hippocampus.

Carolina Tecuatl, Gabriel Herrrera-López, Alejandro Martín-Ávila, Bocheng Yin, Stephen Weber, Germán Barrionuevo, Emilio J Galván

Open access · greenAbstract read
In one paragraph

Article in The European journal of neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Carolina TecuatlDepartamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Calzada de los Tenorios No. 235, México City, 14330, México.
Gabriel Herrrera-LópezDepartamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Calzada de los Tenorios No. 235, México City, 14330, México.
Alejandro Martín-ÁvilaDepartamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Calzada de los Tenorios No. 235, México City, 14330, México.
Bocheng YinDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA.
Stephen WeberDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA.
Germán BarrionuevoDepartment of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.
Emilio J GalvánDepartamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Calzada de los Tenorios No. 235, México City, 14330, México.ORCID 0000-0002-9820-302X
University of Pittsburgh · US

Funding

Role of CyPgs UCHL1 in Ischemic Injury and RecoveryR01NS037459 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GRAHAM, STEVEN H · 1999 to 2018
$5.4M
SENSITIVE AND SELECTIVE DETECTION OF PEPTIDESR01GM044842 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEBER, STEPHEN G. · 1991 to 2018
$4.9M
Single Cell ElectroporationR01GM066018 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEBER, STEPHEN G. · 2003 to 2014
$3.1M
Role of UCH-L1 in Ischemic Injury and RecoveryRF1NS037459 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GRAHAM, STEVEN H · 2020 to 2020
$2.9M
Cyclooxygenase-2 in Ischemia Neuronal InjuryR56NS037459 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GRAHAM, STEVEN H · 2008 to 2008
$379k
NIGMS NIH HHS R01 GM044842NIGMS NIH HHS R01 GM066018NINDS NIH HHS R01 NS037459NINDS NIH HHS R56 NS037459NINDS NIH HHS RF1 NS037459
6 · The paper itself

Abstract

The selective vulnerability of hippocampal area CA1 to ischemia-induced injury is a well-known phenomenon. However, the cellular mechanisms that confer resistance to area CA3 against ischemic damage remain elusive. Here, we show that oxygen-glucose deprivation-reperfusion (OGD-RP), an in vitro model that mimic the pathological conditions of the ischemic stroke, increases the phosphorylation level of tropomyosin receptor kinase B (TrkB) in area CA3. Slices preincubated with brain-derived neurotrophic factor (BDNF) or 7,8-dihydroxyflavone (7,8-DHF) exhibited reduced depression of the electrical activity triggered by OGD-RP. Consistently, blockade of TrkB suppressed the resistance of area CA3 to OGD-RP. The protective effect of TrkB activation was limited to area CA3, as OGD-RP caused permanent suppression of CA1 responses. At the cellular level, TrkB activation leads to phosphorylation of the accessory proteins SHC and Gab as well as the serine/threonine kinase Akt, members of the phosphoinositide 3-kinase/Akt (PI-3-K/Akt) pathway, a cascade involved in cell survival. Hence, acute slices pretreated with the Akt antagonist MK2206 in combination with BDNF lost the capability to resist the damage inflicted with OGD-RP. Consistently, with these results, CA3 pyramidal cells exhibited reduced propidium iodide uptake and caspase-3 activity in slices pretreated with BDNF and exposed to OGD-RP. We propose that PI-3-K/Akt downstream activation mediated by TrkB represents an endogenous mechanism responsible for the resistance of area CA3 to ischemic damage.

Indexed as

AnimalsCell SurvivalGlucoseHippocampusMaleNeuronsNeuroprotective AgentsOxygenPhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktRats, Sprague-DawleyReceptor, trkBSignal TransductionGlucoseNeuroprotective AgentsOxygenPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptor, trkBbrain-derived neurotrophic factorCA3 pyramidal cellsmossy fibersPI-3-K/AktReperfusiontropomyosin receptor kinase B

Identifiers

PMID29480936
PMCPMC5938095
OpenAlexW2791790988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.